Garden City, New York, United States
Commercial healthcare executive with deep expertise leading enterprise commercialization, market access, pricing strategy, and national growth initiatives across pharmaceutical, diagnostics, and healthcare technology portfolios. Over the course of my career, I have led national commercial organizations, secured large-scale GPO and health system agreements, commercialized AI-enabled and SaaS healthcare platforms, and built scalable go-to-market infrastructure supporting complex payer-driven markets. My background spans: • Enterprise commercial strategy • Diagnostics and AI healthcare commercialization • Strategic contracting and market access • National sales leadership • Revenue operations and forecasting • Pricing and distribution strategy • Cross-functional executive leadership Key career highlights include: • Leading a $127M national diagnostics business unit • Securing $125M+ in enterprise growth agreements • Generating $18M in launch-year AI diagnostics revenue • Leading commercial teams of 100+ professionals • Launching SaaS and healthcare technology platforms in competitive markets I’m particularly energized by opportunities where organizations are scaling commercialization infrastructure, expanding enterprise partnerships, optimizing market access strategy, or accelerating growth through modern healthcare solutions. Industries of interest include diagnostics, healthcare AI, specialty pharma, healthcare services, commercialization strategy, and PE-backed healthcare growth organizations.
Leading commercial strategy and operational transformation for a veterinary surgery practice transitioning from a mobile service to a start-up brick-and-mortar facility. Responsible for revenue growth, operational efficiency, pricing strategy, and vendor management while building scalable infrastructure to support higher surgical volume and long-term profitability.
Managed commercialization and expansion of Zoetis’ startup diagnostics division, including market introduction and adoption of the Imagyst AI diagnostic platform. Oversaw national revenue performance, organizational leadership, and expansion of diagnostic infrastructure to support increased testing demand across veterinary practices. REVENUE GROWTH & COMMERCIALIZATION Generated $18M in capital equipment revenue by leading the launch of the Imagyst AI diagnostic platform. Produced $127M in national diagnostics business revenue by directing a 104-person sales and commercial organization. NATIONAL INFRASTRUCTURE EXPANSION Expanded diagnostic capacity nationwide by launching 12 regional diagnostic reference laboratories across the United States. Accelerated recurring diagnostic revenue by aligning marketing, channel, and market access teams to increase platform adoption.
I led enterprise growth initiatives designed to expand market access and secure large-scale contracts with health systems and group purchasing organizations. ENTERPRISE CONTRACTING & MARKET ACCESS Secured $125M in strategic enterprise contracts by negotiating partnerships with major health systems and GPO organizations. Expanded portfolio adoption by designing scalable payer and contracting frameworks. TEAM BUILDING & ORGANIZATIONAL EXPANSION Grew the regional commercial organization from 3 to 9 team members by building a new strategic growth team. Achieved a 100% promotion rate among the original team members through leadership development and mentorship.
I directed national sales operations and commercial infrastructure supporting pharmaceutical portfolio and SaaS-enabled platforms. Generated $11M in first-year SaaS revenue by designing and executing the go-to-market strategy for a new analytics platform. Improved forecasting accuracy by developing Salesforce CRM workflows and ZS Analytics reporting architecture. Tripled national sales coverage by launching and scaling a new channel partner program within 12 months.
I supervised pharmaceutical sales teams covering immunology and neurology product portfolios across the New York and New England markets. Led a veteran team to top performance as a new sales leader Managed formulary relationships with payers representing 1M covered lives. Consistently ranked in the top 1% earning multiple President’s Awards.